Waverley Pharma Inc (WAVE) - Total Liabilities

Latest as of March 2026: CA$3.92 Million CAD ≈ $2.84 Million USD

Based on the latest financial reports, Waverley Pharma Inc (WAVE) has total liabilities worth CA$3.92 Million CAD (≈ $2.84 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how many days can Waverley Pharma Inc fund operations to measure how many days the company can operate on defensive assets alone.

Waverley Pharma Inc - Total Liabilities Trend (2015–2025)

This chart illustrates how Waverley Pharma Inc's total liabilities have evolved over time, based on quarterly financial data. See Waverley Pharma Inc (WAVE) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Waverley Pharma Inc Competitors by Total Liabilities

The table below lists competitors of Waverley Pharma Inc ranked by their total liabilities.

Company	Country	Total Liabilities
CABASSE S.A. EO -50 F:LB0	Germany	€10.20 Million
Cobra Resources PLC LSE:COBR	UK	GBX337.01K
Anexo Group Plc LSE:ANX	UK	GBX115.42 Million
Recon Technology Ltd NASDAQ:RCON	USA	$91.93 Million
Chelverton UK Dividend Trust PLC LSE:SDV	UK	GBX173.00K
Inotiv, Inc. NASDAQ:NOTVQ	USA	$625.32 Million
GRIT Real Estate Income Group LSE:GR1T	UK	GBX738.44 Million
ONETECH SOLUTIONS HOLDINGS BERHAD KLSE:03041	Malaysia	RM3.90 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Waverley Pharma Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Waverley Pharma Inc's balance sheet.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.11	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.44	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	3.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Waverley Pharma Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Waverley Pharma Inc (2015–2025)

The table below shows the annual total liabilities of Waverley Pharma Inc from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	CA$3.82 Million ≈ $2.76 Million	-6.43%
2024-12-31	CA$4.08 Million ≈ $2.95 Million	+95.18%
2023-12-31	CA$2.09 Million ≈ $1.51 Million	+30.87%
2022-12-31	CA$1.60 Million ≈ $1.15 Million	-15.76%
2021-12-31	CA$1.89 Million ≈ $1.37 Million	+30.77%
2020-12-31	CA$1.45 Million ≈ $1.05 Million	-6.42%
2019-12-31	CA$1.55 Million ≈ $1.12 Million	+22.48%
2018-12-31	CA$1.26 Million ≈ $914.54K	-21.04%
2017-12-31	CA$1.60 Million ≈ $1.16 Million	+13556.93%
2016-12-31	CA$11.72K ≈ $8.48K	+10.13%
2015-12-31	CA$10.65K ≈ $7.70K	--

About Waverley Pharma Inc

V:WAVE Canada Biotechnology

Market Cap

$390.63K

CA$540.00K CAD

Market Cap Rank

#31181 Global

#1652 in Canada

Share Price

CA$0.01

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.03

All Time High

CA$0.60